KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Non-Current Liabilities (2016 - 2025)

Emergent BioSolutions (EBS) has 16 years of Total Non-Current Liabilities data on record, last reported at $835.9 million in Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities changed N/A year-over-year to $835.9 million; the TTM value through Sep 2025 reached $835.9 million, changed N/A, while the annual FY2024 figure was $867.8 million, 24.21% down from the prior year.
  • Total Non-Current Liabilities reached $835.9 million in Q3 2025 per EBS's latest filing, roughly flat from $838.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.7 billion in Q4 2022 and bottomed at $835.9 million in Q3 2025.
  • Average Total Non-Current Liabilities over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2021.
  • Peak YoY movement for Total Non-Current Liabilities: surged 36.45% in 2022, then plummeted 34.27% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $1.3 billion in 2021, then soared by 36.45% to $1.7 billion in 2022, then crashed by 34.27% to $1.1 billion in 2023, then decreased by 24.21% to $867.8 million in 2024, then decreased by 3.68% to $835.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $835.9 million in Q3 2025, $838.0 million in Q1 2025, and $867.8 million in Q4 2024.